title: Bradykinin formation during processing for cellular labelling may cause side-effects.
authors.forename: M
authors.initials: M
authors.lastname: Rodrigues
authors.forename: G
authors.initials: G
authors.lastname: Karanikas
authors.forename: S
authors.initials: S
authors.lastname: Granegger
authors.forename: H
authors.initials: H
authors.lastname: Sinzinger
mesh_terms: D000328:Adult; D000368:Aged; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology; D001920:Bradykinin / Q000009:adverse effects* / Q000378:metabolism*; D016264:Dextran Sulfate / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007553:Isotope Labeling; D007962:Leukocytes; D008297:Male; D008875:Middle Aged
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D016264:Dextran Sulfate; D001920:Bradykinin